Xvivo Perfusion’s Fair Value Estimate has recently been revised downward from SEK 345.6 to SEK 322.6. This reflects a modest adjustment in analysts’ price targets. The revision also comes with a ...
GOTHENBURG, SWEDEN / ACCESS Newswire / July 28, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV). The XVIVO Heart Assist Transport and the XVIVO Heart Assist Transport Perfusion Set have ...
Hi, everyone. Hope you're enjoying day 3 of the JPMorgan Healthcare Conference. My name is Vidhushi Taduri, and I'm an associate in the health care team here at JPM. It's my pleasure to introduce ...
Xvivo Perfusion’s stock price target has recently been reaffirmed at SEK 319.6 following the latest analyst review, with a slight increase in the discount rate to 5.77 percent. Revenue growth ...
Xvivo Perfusion (OM:XVIVO) has reported remarkable third-quarter results, with sales reaching SEK 198.48 million and a net income surge to SEK 85.82 million, showcasing its revenue growth and ...
GOTHENBURG, SE / ACCESS Newswire / June 26, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report April-June 2026. The pr ...
XVIVO and the Cleveland Clinic in the US have entered a partnership in advanced analytics, XPS Live, using lung perfusion data from XVIVO's XPS machines. Extracted data from lung perfusion procedures ...
Welcome to XVIVO Q4 Report for 2025. [Operator Instructions] Now I will hand the conference over to CEO, Christoffer Rosenblad; and CFO, Kristoffer Nordstrom. Please go ahead. Thank you so much. Good ...
XVIVO Enters into an Agreement to Acquire its Italian Distributor - Securing a Unique Business Model
XVIVO Perfusion AB (publ) ("XVIVO" or the "Company") has today signed an agreement to acquire 100 percent of the shares in Avionord S.r.l.'s machine and perfusion business ("Avionord M&P") for a ...
GOTHENBURG, SE / ACCESS Newswire / February 20, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Correction: In the press release that was distributed today at 2:00 p.m. CET, the nomination ...
Xvivo Perfusion AB (XVIVO) has delivered a -7.15% change over the past year, with a 52-week range between 160.00 and 322.40. What Is the Average Daily Trading Volume of Xvivo Perfusion AB (XVIVO)? The ...
Xvivo Perfusion AB Annual stock financials by MarketWatch. View the latest XVIVO financial statements, income statements and financial ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results